NaturalVue:

Data that clearly shows efficacy for
pediatric myopia management

This information may describe uses for this product, i.e., Myopia Progression Control, which have not been approved by the FDA for use in the United States. It is intended for educational purposes only. NaturalVue® Multifocal is part of an ongoing clinical trial (RCT) that is studying its effectiveness for myopia progression control. This information has been reviewed and approved by VTI’s Promotional Review Committee.

NaturalVue:

Data that clearly shows efficacy for
pediatric myopia management

Refractive Error
0.41 D (69%) average reduction in refractive error vs. control group

Average refractive error change was less than 0.41 D (69%) for year one.

Axial Length change
0.17 mm (59%) reduction in axial length growth

Average axial length change was less than 0.17 mm per year, (59%) for year one.

  • Real-world data indicates Year 2 myopia progression data likely to trend closely with Year 1 values.
  • Combined with the 6-year data previously published in Clinical Ophthalmology in 2022, and the analysis from 3 independent studies released in September, the 1-year data suggests NaturalVue Multifocal may effectively manage eye growth and refractive error change among children.

AAO 2023

October 11-14, 2023
New Orleans, LA

Global Specialty Lens Symposium

January 17-20, 2024
Las Vegas, NV

Download the PROTECT Factsheet

Email
Registration

* PROgressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial

This information may describe uses for this product, i.e., Myopia Progression Control, which have not been approved by the FDA for use in the United States. It is intended for educational purposes only. NaturalVue® Multifocal is part of an ongoing clinical trial (RCT) that is studying its effectiveness for myopia progression control. This information has been reviewed and approved by VTI’s Promotional Review Committee.

NATURALVUE® INDICATIONS FOR USE
NaturalVue® (etafilcon A) Multifocal 1 Day Disposable Soft Contact Lenses are indicated for daily wear for the correction of refractive ametropia (myopia and hyperopia), and/or presbyopia, and myopia progression control in normal eyes.